Does age-related decline in varicella-zoster immunity increase shingles and PHN risk at age 83?

At age 83, reduced varicella-zoster virus (VZV)-specific cellular immunity is a well-supported contributor to both shingles reactivation and the risk of persistent pain afterward. This reflects impaired T-cell control of latent VZV rather than reduced antibody levels alone.

Clinical evidence

• Aging is associated with lower VZV-specific T-cell proliferation, interferon-γ production, cytotoxic activity, and responder-cell frequency. Some older adults have no measurable VZV-specific memory CD4 response, consistent with reduced containment of latent virus and greater likelihood of herpes zoster.
• Persistent post-herpetic neuralgia (PHN) is particularly consequential at this age: in one primary-care cohort, approximately 21% of adults aged 80–84 developed PHN.
• In a prospective cohort, lower initial VZV-specific cell-mediated immunity predicted subsequent PHN even after adjustment for age and immunocompromised status (odds ratio 13.8; P=.04). Higher early cellular immunity correlated with less acute pain and less PHN.

Mechanisms and clinical modifiers

• Weaker VZV-specific cellular control may allow more extensive viral reactivation and nerve injury during the acute episode, creating conditions for persistent neuropathic pain.
• Acute illness characteristics substantially influence PHN risk: severe acute pain (RR 2.23, 95% CI 1.71–2.92), severe/extensive rash (RR 2.63, 95% CI 1.89–3.66), prodromal pain (RR 2.29, 95% CI 1.42–3.69), and ophthalmic involvement (RR 2.51, 95% CI 1.29–4.86) all predict higher risk.

Prevention implications

• Recombinant zoster vaccination is highly relevant despite immunosenescence, preventing approximately 89% of PHN in adults aged 70 years or older.

Bottom line

• At 83, declining VZV-specific T-cell immunity meaningfully raises susceptibility to shingles and likely contributes to PHN risk, although an individual immune measurement cannot precisely predict who will reactivate or develop persistent pain.